Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
The peptide is classified as a research compound and is not approved for treatment of obesity or any medical condition
[99] A person with cobalamin C disease, a rare autosomal, recessive, inheritance disease which results in combined methylmalonic aciduria and homocystinuria), [100] can be treated with intravenous or intramuscular hydroxocobalamin
B12 shots are generally safe, and side effects are rare
Humbert C, Cordier C, Drut I, Hamrick M, Wong J, Bellamy V, Flaire J, Bakshy K, et al
Furthermore, IM administration of hydroxocobalamin is also the preferred treatment for pediatric patients with intrinsic cobalamin metabolic diseases
Reproductive Biomedicine Online, 59 (2), 255267
US$ 24.93
US$ 20.72
US$ 28.12
US$ 28.96
US$ 26.26
US$ 24.89
US$ 26.88
US$ 22.63
US$ 21.67
